Brenner MK - Search Results

1

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.

Pule MA, Savoldo B, Myers GD, Rossig C, Russell HV, Dotti G, Huls MH, Liu E, Gee AP, Mei Z, Yvon E, Weiss HL, Liu H, Rooney CM, Heslop HE, Brenner MK. Pule MA, et al. Among authors: brenner mk. Nat Med. 2008 Nov;14(11):1264-70. doi: 10.1038/nm.1882. Epub 2008 Nov 2. Nat Med. 2008. PMID: 18978797 Free PMC article.

2

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

3

To be or notch to be.

Brenner M. Brenner M. Nat Med. 2000 Nov;6(11):1210-1. doi: 10.1038/81297. Nat Med. 2000. PMID: 11062524 No abstract available.

4

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A. Yotnda P, et al. Gene Ther. 2001 Jun;8(12):930-7. doi: 10.1038/sj.gt.3301488. Gene Ther. 2001. PMID: 11426333

5

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.

Dotti G, Savoldo B, Takahashi S, Goltsova T, Brown M, Rill D, Rooney C, Brenner M. Dotti G, et al. Exp Hematol. 2001 Aug;29(8):952-61. doi: 10.1016/s0301-472x(01)00668-3. Exp Hematol. 2001. PMID: 11495701 Free article.

6

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: brenner mk. J Immunol. 2002 Jan 15;168(2):909-18. doi: 10.4049/jimmunol.168.2.909. J Immunol. 2002. PMID: 11777989

7

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: brenner mk. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

8

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Rossig C, Bollard CM, Nuchtern JG, Rooney CM, Brenner MK. Rossig C, et al. Among authors: brenner mk. Blood. 2002 Mar 15;99(6):2009-16. doi: 10.1182/blood.v99.6.2009. Blood. 2002. PMID: 11877273 Free article.

9

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

Bollard CM, Rössig C, Calonge MJ, Huls MH, Wagner HJ, Massague J, Brenner MK, Heslop HE, Rooney CM. Bollard CM, et al. Among authors: brenner mk. Blood. 2002 May 1;99(9):3179-87. doi: 10.1182/blood.v99.9.3179. Blood. 2002. PMID: 11964281 Free article.

10

Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.

Dotti G, Savoldo B, Yotnda P, Rill D, Brenner MK. Dotti G, et al. Among authors: brenner mk. Blood. 2002 Jul 1;100(1):200-7. doi: 10.1182/blood.v100.1.200. Blood. 2002. PMID: 12070028 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters